Delivery Order SPE2DE21D7020-SPE2D625F9FA1
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- This delivery order, valued at $5,214.96, was awarded to Boston Scientific Corp on July 29, 2025, for the supply of Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) devices measuring 5.0 x 200mm with a 150cm length. The contract is funded through the Defense Health Agency's Medical Supply Chain division and employs fixed-price pricing with economic price adjustment terms. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, with an ultimate...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp has been awarded a delivery order valued at $21,828.61 for Agent Drug Coated Balloon devices under a fixed price contract with economic price adjustment provisions. The contract was awarded on July 22, 2025, by the Defense Health Agency's Medical Supply Chain and is scheduled for completion by July 29, 2025. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular medical devices to federal healthcare agencies. The award is not...
- This is a $43,399.46 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract is for the delivery of RANGER GLOBAL DCB OTW 5.0 X 200MM 150CM medical devices, which are drug-coated balloons used for cardiovascular procedures. This contract is not set aside and is part of Boston Scientific's broader portfolio of federal contracts with agencies like the...
- This federal contract award is a Delivery Order awarded to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $6,897.46, is for the supply of a RANGER GLOBAL DCB OTW 4.0 X 60MM 135CM medical device. The contract is funded by the Defense Logistics Agency's (DLA) Medical Supply Chain, which supports healthcare services for military personnel, veterans, and federal medical facilities. The contract has a fixed price with...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...
- This delivery order, awarded on July 18, 2025, provides Boston Scientific Corp with a fixed-price contract valued at $3,948.58 for the supply of Ranger Global DCB OTW 6.0 x 40mm 80cm medical devices. The award was made by the Defense Health Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring medical equipment and supplies for Department of Defense healthcare operations. The contract utilizes economic price adjustment terms and is scheduled for completion...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F9FA1Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston Scientific's facility in Marlborough, MA. This delivery order represents a continuation of Boston Scientific's extensive federal contracting relationship, through which the company supplies specialized cardiovascular and interventional medical devices to federal healthcare agencies including the Department of Veterans Affairs and Defense Health Agency. As a major federal contractor within the medical device sector, Boston Scientific holds multiple indefinite delivery vehicles with federal agencies, including a single-award blanket purchase agreement with the Defense Health Agency valued at $750,000 through March 30, 2030, for radiation treatment devices. The company's federal portfolio encompasses a comprehensive range of advanced medical technologies such as implantable cardioverter defibrillators, pacemakers, stents, catheters, and diagnostic equipment. This delivery order for drug-coated balloon devices aligns with Boston Scientific's core competency in providing critical cardiovascular intervention technologies to support federal healthcare operations and medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.9k | 7/29/25 |